Symetis

Symetis

Minimally invasive heart valve replacement therapies for patients suffering from heart valve diseases. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
AUD673m (Public information from Apr 2017)
Company register number CH-020.3.025.035-4
Ecublens Canton of Vaud (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR2015201620172018
Revenues4.6m4.7m4.3m4.4m
% growth-1 %(8 %)4 %

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
-

N/A

-

$9.6m

Series A

$21.3m

Series B

$25.8m

Series C

N/A

Late VC

N/A

Series D
*

€396m

Valuation: €396m

84.8x EV/LTM Revenues

Acquisition
Total FundingAUD87.6m

Recent News about Symetis

Edit
More about Symetisinfo icon
Edit

Symetis is a pioneering company in the medical technology sector, specializing in innovative solutions that enhance patient care. The company operates in the healthcare market, focusing on cardiovascular, gastroenterology, and urology specialties. Symetis serves a diverse range of clients, including hospitals, clinics, and medical professionals who require advanced medical devices to improve patient outcomes. The business model revolves around the development, manufacturing, and sale of high-quality medical devices such as single-use duodenoscopes, pacemakers, defibrillators, and stents. Revenue is generated through direct sales to healthcare providers and partnerships with medical institutions. Symetis is committed to sustainability and corporate social responsibility, ensuring that their operations positively impact communities worldwide.

Keywords: medical technology, cardiovascular devices, gastroenterology, urology, single-use duodenoscope, pacemakers, defibrillators, stents, patient care, healthcare innovation.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Symetis

Edit
Middle Peak Medical
ACQUISITION by Symetis Feb 2017